News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Isabelle Ray-Coquard: New publication from ENGOTov25 Paola-1 study
centreleonberard.fr
Dec 12, 2024, 16:06

Isabelle Ray-Coquard: New publication from ENGOTov25 Paola-1 study

Isabelle Ray-Coquard, Medical Oncologist at Léon Bérard Center, shared a post on LinkedIn, about a paper by her and colleagues, published in Annals of Oncology:

“Paola-1 publications, new episode in Annals of Oncology 2024 revealing that subsequent therapies can be impacted differently after 1st line maintenance with parpi and bevacizumab or bevacizumab alone…

Very proud to share this academic international collaborative new publication from ENGOTov25 Paola-1 study.”

“Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial.”

Authors: P. Harter, C. Marth, M. Mouret-Reynier, E. Pujade-Lauraine, I. Ray-Coquard et al.

Isabelle Ray-Coquard: New publication from ENGOTov25 Paola-1 study

More posts featuring Isabelle Ray-Coquard.

Annals of Oncology cancer ENGOTov25 Paola-1 Isabelle Ray-Coquard OncoDaily Oncology
Special Coverage
Blog
Jan 11, 2025, 21:25
Petros Grivas: My heart goes to people in the areas affected by the LA fires
Science
Jan 11, 2025, 21:15
Senthil Kumar: Comprehensive Overview of First-Line Treatment for Metastatic Esophageal Cancer
Blog
Jan 11, 2025, 21:13
Sachin Jain: SCAN Group is committed to supporting each of you during this difficult time
Insight
Jan 11, 2025, 21:11
Adding Blinatumomab to Standard Treatment for Pediatric B-cell ALL
Blog
Jan 11, 2025, 21:09
Lisa Lacasse: ACS CAN's virtual screening of 'Trans Dudes with Lady Cancer'
Science
Jan 11, 2025, 17:09
Biomarker testing in lung cancer: from bench to bedside
Insight
Jan 11, 2025, 16:54
Patrick Forde: Neoadjuvant Nivolumab Plus Ipilimumab Versus Chemotherapy in Resectable Lung Cancer
Blog
Jan 11, 2025, 16:43
Dani Ally Ngayonga is a new member of Cancer Fight Tanzania
Blog
Jan 11, 2025, 16:33
Registration is open for the 8th Annual Meeting of the IACH
Blog
Jan 11, 2025, 16:23
Monica Bertagnolli: Could Engineered Immune Cells Be Used to Treat People with Autoimmune Diseases and Organ Transplants
Insight
Jan 11, 2025, 16:20
Yan Leyfman: iPSC-derived CAR-NK cell therapy with three antitumor modalities
Blog
Jan 11, 2025, 16:15
Roupen Odabashian: The third lesson on using AI for learning